Browsing by Author Central Clinical School: Addiction Medicine

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 261  next >
Issue DateTitleAuthor(s)Citation
2015Aboriginal and Torres Strait Islander AustraliansConigrave, Katherine; Lee, Kim San Kylie; Freeburn, Bradley; Central Clinical School: Addiction Medicine; Central Clinical School: MedicineAboriginal and Torres Strait Islander Australians in Addiction Medicine: Principles and Practice, IP Communications, 2015, pp. 414-424
2013Acceptability and effect of a community-based alcohol education program in rural Sri LankaDawson, Andrew; Abeyasinge, R; Siriwardhana, P; Central Clinical School: Addiction MedicineAcceptability and effect of a community-based alcohol education program in rural Sri Lanka, Alcohol and Alcoholism, vol.48, 2, 2013,pp 250-256
2008Acceptability of hepatitis C virus testing methods among injecting drug usersDay, Carolyn; Bates, A; Doab, A; Holden, J; Maher, L; Thein, Hla Hla; van Beek, I; White, B; Central Clinical School: Addiction MedicineAcceptability of hepatitis C virus testing methods among injecting drug users, Drug and Alcohol Review, vol.27,(N/A),2008,pp 666-670
2012The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literatureConigrave, Katherine; Day, Carolyn; Dawson, Angela; Mofizul Islam, M.; Topp, Libby; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineThe accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature, International Journal of Drug Policy, vol.23, 2, 2012,pp 94-102
2006Action is required to reduce kava supply in Arnhem Land . . . again!Clough, Alan; Conigrave, Katherine; Currie, Bart; Yunupingu, Maymuna W.; School of Public Health: Public Health; Central Clinical School: Addiction Medicine; MedicineAction is required to reduce kava supply in Arnhem Land . . . again!, Medical Journal of Australia, vol.184,(2),2006,pp 91-92
2013Addressing high rates of smoking in remote Aboriginal communities: New evidence for GPsConigrave, Katherine; Clough, Alan R.; Hindmarsh, Elizabeth; Ivers, Rowena; Robertson, Jan; Central Clinical School: Addiction MedicineAddressing high rates of smoking in remote Aboriginal communities: New evidence for GPs, Australian Family Physician, vol.42, 6, 2013,pp 492-496
2016ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014Brett, Jonathan; Daniels, Benjamin; Cairns, Rose; Wood, Danielle A; Central Clinical School: Addiction Medicine; PharmacyADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004-2014, Medical Journal of Australia, vol.204, 4, 2016,pp 154.e1-154.e7
2005Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage.Conigrave, Katherine; Ascherio, A; Camargo, Carlos A.; Kawachi, I; Mittleman, Murray A.; Mukamal, Kenneth J.; Rimm, Eric B.; Stampfer, Meir J.; Willett, Walter C.; Central Clinical School: Addiction MedicineAlcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage., Annals of internal medicine, vol.142,(1),2005,pp 11-19
2012The Alcohol Awareness project: community education and brief intervention in an urban Aboriginal settingConigrave, Katherine; Ella, Stephen; Lee, Kim; Becker, Karen; Caroll, Therese; Freeburn, Bradley; Freeman, Brian; Kiel, Keren A; Simpson, Lynette; Wade, Vicki; Central Clinical School: Addiction Medicine; School of Public Health: Public Health; Central Clinical School: MedicineThe Alcohol Awareness project: community education and brief intervention in an urban Aboriginal setting, Health Promotion Journal of Australia, vol.23, 3, 2012,pp 219-225
2005Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatmentConigrave, Katherine; Haber, Paul; Wallace, Cate; Watson, Bianca; Whitfield, John; Wurst, Freidrich M; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction Medicine; School of Public Health: Public Health; School of Public Health: Public Health; Central Clinical School: MedicineAlcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment, Alcoholism: Clinical and Experimental Research, vol.29,(S1),2005,pp 32A-32A
2003Alcohol for the prevention of type 2 diabetes mellitus?Conigrave, Katherine; Rimm, Eric B; Central Clinical School: Addiction MedicineAlcohol for the prevention of type 2 diabetes mellitus?, Treatments in Endocrinology, vol.2,(3),2003,pp 145-152
2016Alcohol use disordersHaber, Paul; Connor, Jason P; Hall, Wayne; Central Clinical School: Addiction MedicineAlcohol use disorders, The Lancet, vol.387, 10022, 2016,pp 988-998
2016Alcohol use disorders in AustraliaHaber, Paul; Morley, Kirsten; Freyer, C. H.; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineAlcohol use disorders in Australia, Internal Medicine Journal, vol.46, 11, 2016,pp 1259-1268
2016Alcohol use disorders in AustraliaHaber, Paul; Morley, Kirsten; Freyer, C. H.; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineAlcohol use disorders in Australia, Internal Medicine Journal, vol.46, 11, 2016,pp 1259-1268
2003Alcohol use in ChinaCochrane, Johanne; Conigrave, Katherine; Chen, Haibin; Hao, Wei; School of Public Health: Public Health; Central Clinical School: Addiction MedicineAlcohol use in China, Alcohol and Alcoholism, vol.38,(6),2003,pp 537-542
2010Alcohol, Signaling, and ECM TurnoverHaber, Paul; Apte, Minoti; Darwanto, Agus; De Villiers, Willem; Dooley, Steven; El-Guindy, Nympha; et al, various; Kundu, Gopal; Mari, Montserrat; Neuman, Manuela G; Seth, Devanshi; Vonlaufen, A; Xu, Z; Central Clinical School: Addiction MedicineAlcohol, Signaling, and ECM Turnover, Alcoholism: Clinical and Experimental Research, vol.34, 1,pp 1-15
2016Alcoholic Liver Disease in Asia, Europe, and North AmericaHaber, Paul; McCaughan, Geoffrey William; Liangpunsakul, Suthat; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteAlcoholic Liver Disease in Asia, Europe, and North America, Gastroenterology, vol.150, 8, 2016,pp 1786-1797
2015Alcopops, taxation and harm: a segmented time series analysis of emergency department presentationsDinh, Michael; Haber, Paul; Byrnes, Joshua; Cretikos, Michelle; Gale, Marianne; Hayen, A; MacIntyre, C Raina; Morton, Patricia; Muscatello, David; Shakeshaft, Anthony; Central Clinical School: Medicine; Central Clinical School: Addiction MedicineAlcopops, taxation and harm: a segmented time series analysis of emergency department presentations, BMC Public Health, vol.15, 1, 2015,pp 468-N/A
2016Alprazolam use and related harm among opioid substitution treatment clients ` 12 months follow up after regulatory reschedulingDeacon, Rachel; Leung, Stefanie; Lintzeris, Nicholas; Monds, Lauren Ann; Cubitt, Tim; Ezard, Nadine; Larance, Briony; Nielsen, Elsebet Ostergaard; Rivas, G R; Central Clinical School: Addiction Medicine; Central Clinical School: Medicine; Central Clinical School: Psychological Medicine; Central Clinical School: MedicineAlprazolam use and related harm among opioid substitution treatment clients ` 12 months follow up after regulatory rescheduling, International Journal of Drug Policy, vol.36, N/A, 2016,pp 104-111
2016Alprazolam use and related harm among opioid substitution treatment clients ` 12 months follow up after regulatory reschedulingDeacon, Rachel; Leung, Stefanie; Lintzeris, Nicholas; Monds, Lauren Ann; Cubitt, Tim; Ezard, Nadine; Larance, Briony; Nielsen, Elsebet Ostergaard; Rivas, G R; Central Clinical School: Addiction Medicine; Central Clinical School: Medicine; Central Clinical School: Psychological Medicine; Central Clinical School: MedicineAlprazolam use and related harm among opioid substitution treatment clients ` 12 months follow up after regulatory rescheduling, International Journal of Drug Policy, vol.36, N/A, 2016,pp 104-111